Zydus Wellness Ltd
Zydus Wellness operates as an integrated consumer Company with business encompassing the entire value chain in the development, production, marketing and distribution of health and wellness products. The product portfolio of the Company includes brands like Sugar free, Everyuth and Nutralite.(Source : 202003 Annual Report Page No: 83)
- Market Cap ₹ 15,693 Cr.
- Current Price ₹ 493
- High / Low ₹ 612 / 358
- Stock P/E 349
- Book Value ₹ 127
- Dividend Yield 0.24 %
- ROCE 1.69 %
- ROE 1.14 %
- Face Value ₹ 2.00
Pros
- Company is almost debt free.
- Company is expected to give good quarter
- Company has been maintaining a healthy dividend payout of 108%
Cons
- Stock is trading at 3.89 times its book value
- Company has a low return on equity of 0.89% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 219 | 200 | 225 | 264 | 255 | 153 | 114 | 216 | 251 | 245 | 354 | 582 | 594 | |
| 126 | 122 | 137 | 152 | 182 | 174 | 164 | 222 | 213 | 212 | 312 | 498 | 514 | |
| Operating Profit | 93 | 78 | 88 | 112 | 72 | -21 | -50 | -5 | 38 | 33 | 42 | 84 | 80 |
| OPM % | 42% | 39% | 39% | 42% | 28% | -14% | -44% | -2.5% | 15% | 13% | 12% | 14% | 14% |
| 20 | 30 | 25 | 28 | 57 | 109 | -60 | 15 | 13 | 18 | 12 | 1 | 5 | |
| Interest | 0 | 0 | 0 | 2 | 30 | 140 | 75 | 2 | 1 | 3 | 4 | 11 | 12 |
| Depreciation | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 10 | 25 | 25 |
| Profit before tax | 109 | 104 | 109 | 134 | 97 | -55 | -188 | 5 | 47 | 45 | 40 | 49 | 48 |
| Tax % | -0% | 1% | -1% | 0% | 1% | -26% | -3% | -143% | -41% | 25% | 25% | 23% | |
| 109 | 103 | 109 | 134 | 96 | -41 | -182 | 13 | 66 | 34 | 30 | 38 | 38 | |
| EPS in Rs | 5.58 | 5.28 | 5.60 | 6.85 | 3.34 | -1.41 | -5.72 | 0.40 | 2.09 | 1.06 | 0.93 | 1.18 | 1.21 |
| Dividend Payout % | 22% | 25% | 23% | 23% | 30% | -71% | -17% | 251% | 48% | 94% | 128% | 101% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 39% |
| 3 Years: | 32% |
| TTM: | 38% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -8% |
| 5 Years: | 23% |
| 3 Years: | -11% |
| TTM: | 60% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 1% |
| 3 Years: | 16% |
| 1 Year: | 7% |
| Return on Equity | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 1% |
| 3 Years: | 1% |
| Last Year: | 1% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 39 | 39 | 39 | 39 | 58 | 58 | 64 | 64 | 64 | 64 | 64 | 64 |
| Reserves | 367 | 440 | 518 | 652 | 3,268 | 3,157 | 3,956 | 3,937 | 3,971 | 3,972 | 3,970 | 3,969 |
| 0 | 0 | 25 | 25 | 1,566 | 1,516 | 50 | 46 | 0 | 51 | 130 | 181 | |
| 45 | 19 | 23 | 23 | 62 | 72 | 47 | 44 | 32 | 29 | 88 | 60 | |
| Total Liabilities | 451 | 498 | 605 | 739 | 4,954 | 4,803 | 4,116 | 4,090 | 4,067 | 4,116 | 4,251 | 4,273 |
| 44 | 43 | 40 | 38 | 37 | 43 | 44 | 45 | 54 | 54 | 432 | 420 | |
| CWIP | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 0 | 4 | 8 | 5 |
| Investments | 100 | 209 | 254 | 294 | 3,690 | 3,528 | 3,671 | 3,683 | 3,698 | 3,676 | 3,678 | 3,671 |
| 306 | 245 | 310 | 407 | 1,226 | 1,231 | 400 | 360 | 314 | 382 | 133 | 178 | |
| Total Assets | 451 | 498 | 605 | 739 | 4,954 | 4,803 | 4,116 | 4,090 | 4,067 | 4,116 | 4,251 | 4,273 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 89 | 79 | 88 | 113 | 86 | -20 | -52 | -16 | 37 | 26 | 40 | 35 | |
| 70 | -19 | -78 | -109 | -4,131 | 267 | 816 | 39 | 1 | -47 | -88 | -32 | |
| -27 | -58 | -6 | -2 | 4,049 | -260 | -710 | -38 | -79 | 15 | 43 | -0 | |
| Net Cash Flow | 131 | 1 | 4 | 2 | 4 | -13 | 54 | -15 | -42 | -6 | -5 | 3 |
| Free Cash Flow | 93 | 77 | 87 | 111 | 82 | -28 | -55 | -21 | 25 | 20 | 29 | 27 |
| CFO/OP | 98% | 103% | 100% | 99% | 123% | 96% | 109% | 255% | 96% | 80% | 90% | 44% |
Ratios
Standalone / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 1 | 0 | 1 | 1 | 9 | 1 | 5 | 19 | 4 | 12 | 25 | 17 |
| Inventory Days | 25 | 23 | 38 | 32 | 24 | 57 | 67 | 22 | 20 | 23 | 43 | 28 |
| Days Payable | 58 | 71 | 93 | 84 | 106 | 151 | 158 | 75 | 44 | 45 | 54 | 43 |
| Cash Conversion Cycle | -32 | -48 | -55 | -50 | -73 | -93 | -85 | -34 | -20 | -10 | 13 | 3 |
| Working Capital Days | -63 | -23 | -61 | -50 | -104 | -65 | -145 | -59 | 144 | 63 | -76 | 0 |
| ROCE % | 30% | 23% | 21% | 21% | 4% | 2% | 0% | 0% | 1% | 1% | 1% | 2% |
Insights
In beta| Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sugar Free Market Share (Sugar substitute category) % |
|
|||||||
| Complan Market Share (Nutrition drink / HFD category) % |
||||||||
| Everyuth Market Share (Facial cleansing overall category) % |
||||||||
| Glucon-D Market Share (Glucose powder category) % |
||||||||
| Nycil Market Share (Prickly heat powder category) % |
||||||||
| Organised Trade Saliency (% of domestic revenue) % |
||||||||
| Direct Distribution Reach (Company direct coverage in lakhs of outlets) lakhs of outlets |
||||||||
| Total Reach (Distribution - stores in millions, Nielsen reported) million stores |
||||||||
Extracted by Screener AI
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Closure of Trading Window
-
Announcement under Regulation 30 (LODR)-Change in Management
- CMO Arijit Sengupta resigned effective September 18, 2026.
-
Clarification On Volume Movement
- Zydus Wellness clarified no undisclosed event behind recent share volume increase.
-
Clarification sought from Zydus Wellness Ltd
- Exchange has sought clarification from Zydus Wellness Ltd on September 8, 2026, with reference to Movement in Volume.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Concalls
-
Aug 2026Transcript PPT REC
-
May 2026Transcript PPT REC
-
Mar 2026PPT
-
Mar 2026PPT
-
Feb 2026Transcript PPT REC
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT
-
Jul 2025PPT
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Feb 2024PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
May 2022PPT
-
Feb 2022Transcript PPT
-
Oct 2021Transcript
-
Aug 2021Transcript
-
Aug 2021Transcript
-
May 2021Transcript
-
Jan 2021Transcript
-
Oct 2020Transcript
-
Sep 2020PPT
-
Jul 2020Transcript
-
May 2020Transcript
-
Jan 2020Transcript
-
Nov 2019Transcript
-
Jul 2019Transcript
-
May 2019Transcript
-
Feb 2019Transcript
-
Oct 2018Transcript
-
Jul 2018Transcript
-
May 2018Transcript
-
Jan 2018Transcript
-
Nov 2017Transcript
-
Feb 2017PPT
-
Nov 2016Transcript PPT
-
Jul 2016Transcript
-
Jun 2016PPT
Business Segments:[1]
Zydus Wellness operates primarily in the consumer wellness sector. Its key segments include:
a)Food & Nutrition: Notable brands and products such as Glucon-D, Complan, and Sugar-Free.
b) Personal Care: This segment covers products like Everyuth, Scrubs Peel-off masks, and Nycil Prickly Heat Powder.